These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16734820)

  • 1. Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation.
    Cauwenberghs S; Feijge MA; Hageman G; Hoylaerts M; Akkerman JW; Curvers J; Heemskerk JW
    Transfusion; 2006 Jun; 46(6):1018-28. PubMed ID: 16734820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
    Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
    Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet ADP response deteriorates in synthetic storage media.
    Keuren JF; Cauwenberghs S; Heeremans J; de Kort W; Heemskerk JW; Curvers J
    Transfusion; 2006 Feb; 46(2):204-12. PubMed ID: 16441596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
    Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
    Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation and relocalization of the platelet P2Y receptors after activation: a way to avoid loss of hemostatic properties?
    Baurand A; Eckly A; Hechler B; Kauffenstein G; Galzi JL; Cazenave JP; Léon C; Gachet C
    Mol Pharmacol; 2005 Mar; 67(3):721-33. PubMed ID: 15602005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
    Goto S; Tamura N; Ishida H; Ruggeri ZM
    J Am Coll Cardiol; 2006 Jan; 47(1):155-62. PubMed ID: 16386680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.
    Gachet C
    Pharmacol Ther; 2005 Nov; 108(2):180-92. PubMed ID: 15955565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
    Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The P2 receptors in platelet function.
    Hechler B; Cattaneo M; Gachet C
    Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 2 stimulation of platelets is mediated by purinergic P2X1-dependent Ca2+ mobilisation, cyclooxygenase and purinergic P2Y1 and P2Y12 receptor activation.
    Kälvegren H; Skoglund C; Helldahl C; Lerm M; Grenegård M; Bengtsson T
    Thromb Haemost; 2010 Feb; 103(2):398-407. PubMed ID: 20024498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: effect of agonists, pH, and plasma and saline resuspension.
    Valeri CR; Macgregor H; Ragno G
    Transfusion; 2005 Apr; 45(4):596-603. PubMed ID: 15819682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist action of adenosine triphosphates at the human P2Y1 receptor.
    Palmer RK; Boyer JL; Schachter JB; Nicholas RA; Harden TK
    Mol Pharmacol; 1998 Dec; 54(6):1118-23. PubMed ID: 9855642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation.
    Jantzen HM; Gousset L; Bhaskar V; Vincent D; Tai A; Reynolds EE; Conley PB
    Thromb Haemost; 1999 Jan; 81(1):111-7. PubMed ID: 10348701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-steady state study of beta-adrenergic and purinergic receptor interaction in C6 cell membranes: undelayed balance between positive and negative coupling to adenylyl cyclase.
    Valeins H; Merle M; Labouesse J
    Mol Pharmacol; 1992 Dec; 42(6):1033-41. PubMed ID: 1336111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoblast responses to nucleotides increase during differentiation.
    Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
    Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of purine nucleotides on purinergic P2 platelet receptors by small angle light scattering].
    Sakaev MR; Mindukshev IV; Lesiovskaia EE; Petrishchev NN; Krivchenko AI
    Eksp Klin Farmakol; 2000; 63(3):65-9. PubMed ID: 10934601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the influence of nucleotidases on the apparent activity of exogenous ATP and ADP at P2Y1 receptors.
    Vigne P; Breittmayer JP; Frelin C
    Br J Pharmacol; 1998 Oct; 125(4):675-80. PubMed ID: 9831901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca2+ influx through P2X1 receptors amplifies P2Y1 receptor-evoked Ca2+ signaling and ADP-evoked platelet aggregation.
    Jones S; Evans RJ; Mahaut-Smith MP
    Mol Pharmacol; 2014 Sep; 86(3):243-51. PubMed ID: 24923466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.